Best Biotech Stocks that Surge in Morning Session (GENT, CTIC, NVAX, AEZS, SOMX, GNVC)
Top Biotech Stocks.
(EMAILWIRE.COM, March 24, 2010 ) Dallas, Tx - Gentium S.p.A. (ADR) (NASDAQ:GENT) is amongst the top gainer in the early morning trade and sky rocketed 70.87% to $3.11 after it announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation (EBMT) 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program.
You can subscribe to our Daily Stock Alerts by visiting: http://www.LiquidTycoon.com .
Cell Therapeutics, Inc. (NASDAQ:CTIC) zoomed 15.48% to $0.735. Hagens Berman Sobol Shapiro LLP (Hagens Berman) announced that it has filed a class action lawsuit in the United States District Court for the Western District of Washington on behalf of purchasers of the common stock of Cell Therapeutics, Inc. between May 5, 2009 and February 8, 2010, inclusive (Class Period), seeking to pursue remedies under the Securities Exchange Act of 1934. The complaint charges Cell Therapeutics and certain of its officers and executives with violations of the Exchange Act. The Company describes Pixantrone as a topoisomerase II inhibitor with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. The stock has a 52-week range of $0.12-$2.23.
Novavax, Inc. (NASDAQ:NVAX) soared 11.97% to $2.62 after it announced the positive results from the entire 1,000 subject Stage A of its two stage pivotal study evaluating the safety and immunogenicity of Novavax's unadjuvanted 2009 A/H1N1 virus-like particle (VLP) pandemic influenza vaccine. The data showed that safety and immunogenicity of the vaccine were consistent with preliminary results disclosed earlier from the first 500 volunteers of Stage A where the vaccine was found to be well tolerated and immunogenic at all three dose levels tested. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) climbed 2.41% to $0.850 today reported financial and operating results as at and for the fourth quarter and the full year ended December 31, 2009. Revenues were $40.2 million for the quarter ended December 31, 2009, compared to $7.2 million for the same quarter in 2008. Revenues were $63.2 million for the year ended December 31, 2009, compared to $38.5 million for the year ended December 31, 2008.
Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) surged 3.27% to $9.17. The stock has a 52-week range of $0.31-$10.60. The stock surged 732% in this year.
GenVec, Inc. (NASDAQ:GNVC) has spurted 1.66% and is trading at $3.06. The stock has a 52-week range of $0.39-$3.35. The stock surged 1782% in this year.
About http://www.LiquidTycoon.com
Liquid Tycoon provides stock news alerts for the investors. Many of our members have gained thousands of dollars using our stock market investment news. We also provide information on penny stocks. We send our members, stock newsletter on hot stocks, stocks in focus, technical stocks, stocks to watch etc. You can also feature your business on our website by contacting us at the email given here.
###
Press release service and press release distribution by EmailWire.Com - http://www.emailwire.com/press_release_distribution_lists.php
You can subscribe to our Daily Stock Alerts by visiting: http://www.LiquidTycoon.com .
Cell Therapeutics, Inc. (NASDAQ:CTIC) zoomed 15.48% to $0.735. Hagens Berman Sobol Shapiro LLP (Hagens Berman) announced that it has filed a class action lawsuit in the United States District Court for the Western District of Washington on behalf of purchasers of the common stock of Cell Therapeutics, Inc. between May 5, 2009 and February 8, 2010, inclusive (Class Period), seeking to pursue remedies under the Securities Exchange Act of 1934. The complaint charges Cell Therapeutics and certain of its officers and executives with violations of the Exchange Act. The Company describes Pixantrone as a topoisomerase II inhibitor with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. The stock has a 52-week range of $0.12-$2.23.
Novavax, Inc. (NASDAQ:NVAX) soared 11.97% to $2.62 after it announced the positive results from the entire 1,000 subject Stage A of its two stage pivotal study evaluating the safety and immunogenicity of Novavax's unadjuvanted 2009 A/H1N1 virus-like particle (VLP) pandemic influenza vaccine. The data showed that safety and immunogenicity of the vaccine were consistent with preliminary results disclosed earlier from the first 500 volunteers of Stage A where the vaccine was found to be well tolerated and immunogenic at all three dose levels tested. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) climbed 2.41% to $0.850 today reported financial and operating results as at and for the fourth quarter and the full year ended December 31, 2009. Revenues were $40.2 million for the quarter ended December 31, 2009, compared to $7.2 million for the same quarter in 2008. Revenues were $63.2 million for the year ended December 31, 2009, compared to $38.5 million for the year ended December 31, 2008.
Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) surged 3.27% to $9.17. The stock has a 52-week range of $0.31-$10.60. The stock surged 732% in this year.
GenVec, Inc. (NASDAQ:GNVC) has spurted 1.66% and is trading at $3.06. The stock has a 52-week range of $0.39-$3.35. The stock surged 1782% in this year.
About http://www.LiquidTycoon.com
Liquid Tycoon provides stock news alerts for the investors. Many of our members have gained thousands of dollars using our stock market investment news. We also provide information on penny stocks. We send our members, stock newsletter on hot stocks, stocks in focus, technical stocks, stocks to watch etc. You can also feature your business on our website by contacting us at the email given here.
###
Press release service and press release distribution by EmailWire.Com - http://www.emailwire.com/press_release_distribution_lists.php
Contact Information:
Liquid Tycoon
Jim
Tel: 214 556 6798
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Liquid Tycoon
Jim
Tel: 214 556 6798
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Satellite TV for PC Watch Streaming Tv Right on Your PC Satellitetelevisionforpc.com Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |